Page last updated: 2024-08-17

prednisone and carmustine

prednisone has been researched along with carmustine in 317 studies

Research

Studies (317)

TimeframeStudies, this research(%)All Research%
pre-1990159 (50.16)18.7374
1990's88 (27.76)18.2507
2000's44 (13.88)29.6817
2010's21 (6.62)24.3611
2020's5 (1.58)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Alberts, DS; Durie, BG; Salmon, SE1
Bakemeier, RF; Bennett, JM; Carbone, PP; Ezdinli, E; Lenhard, RE1
Adler, S; Han, T; Shimaoka, K; Tsukada, Y1
Bennett, JM; Carbone, PP; Ezdinli, E; Johnson, GJ; Lenhard, RE; Pocock, SJ1
Arosio, A; Burdick, L; Cunietti, E; Eridani, S; Maggio, L; Periti, M; Perrone, G1
Carcassonne, Y; Foa, J1
Canellos, GP; Gralnick, HR; Rosenthal, S; Whang-Peng, J1
Burgert, EO; Cuttner, J; Degnan, T; Del Duca, V; Falkson, G; Freeman, A; Hakami, N; Holland, J; Koch, K; Kung, FH; Lanzkowsky, P; Leone, LA; Nawabi, IU; Nythan, WL; Pajak, TF; Patterson, RB; Pluess, H; Ruymann, F1
Harrison, DT; Neiman, PE1
Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA1
Amorisi, EL; Bennett, JM; Costello, W; Ezdinli, EZ; Horton, J; Lenhard, RE; Stolbach, L; Wolter, J1
Bank, A; Blom, J; Brunner, K; Coleman, M; Cornell, C; Cuttner, J; Falkson, G; Glidewell, O; Harley, JB; Haurani, F; Henry, P; Holland, JF; James, GW; Leone, L; Martz, G; Maurice, P; Nissen, NI; Pajak, TF; Pedersen-Bjergaard, J; Sawitsky, A; Seligman, B; Senn, HJ; Shapiro, L; Spurr, CL; Stutzman, L1
Buonanno, G; Cantore, N; Castaldo, C; Russolillo, S; Tortarolo, M1
McIntyre, OR1
Buonanno, G; Castaldo, C; Gonnella, F; Russolillo, S; Tortarolo, M; Valente, A1
Coleman, M; Cooper, MR; Cuttner, J; Harley, JB; Kochwa, S; McIntyre, OR; Pajak, TF1
Dalton, JF; Hastedt, R; Marshall, D; Raymond, LW; Richter, JE1
Green, MR1
Bartolucci, AA; Cohen, HJ; Durant, JR; Johnson, L; Larsen, WE; Silberman, HR1
Blom, J; Gailani, S; Holland, JF; Kyle, RA; McIntyre, OR; Pajak, TF; Seligman, BR1
Bailey, AJ; Bergsagel, DE; Langley, GR; MacDonald, RN; Miller, AB; White, DF1
Miller, S; Perrotta, AL1
Bennett, JM; Berard, CW; Carbone, PP; Costello, W; Ezdinli, EZ; Icli, F1
Alexanian, R; Bonnet, J; Gehan, E; Haut, A; Salmon, S; Weick, J1
Case, DC; Clarkson, BD; Lee, DJ1
Solomon, A1
Ghatak, NR; Sawyer, DR1
Klahr, C; Presant, CA1
Bartolucci, A; Dorfman, R; Durant, JR; Gams, RA; Velez-Garcia, E; Wirtschafter, D1
Bartolucci, A; Dorfman, RF; Durant, JR; Gams, RA; Velez-Garcia, E1
Salmon, SE1
Bergsagel, DE2
Bergsagel, DE; Pruzanski, W1
Capra, JD; McLaughlin, CL; Solomon, A1
Aungst, CW; Ezdinli, E; Kaufman, JH; Stutzman, L1
Adamson, RH; Sieber, SM1
Clarkson, BD; Cunningham, I; Dowling, MD; Gee, TS; Haghbin, M; Middleman, MP1
Jochimsen, PR; Lawton, RL; Pearlman, NW1
Pocock, SJ; Simon, R1
Chan, YK; Dorfman, R; Durant, JR; Loeb, V1
Chang, TC; Sokal, JE; Stutzman, L1
Burchenal, JH; D'Angio, GJ; Exelby, PR; Lieberman, PH; Murphy, ML; Wollner, N1
Burchenal, JH; D'Angio, G; Exelby, P; Lieberman, PH; Murphy, ML; Wollner, N1
Bosly, A; Doyen, C; Ferrant, A; Machiels, JP; Martiat, P; Michaux, JL1
Hernando, JC; Pais, JR; Pascual, J; Pérez Vaquero, MA; Sureda, A1
Azais, I; Bernard, JF; Doyen, C; Grosbois, B; Laporte, JP; Le Loet, X; Menard, JF; Michaux, JL; Monconduit, M; Pollet, JP1
Bastion, Y; Coiffier, B; Tigaud, JD1
Matsuzaki, M; Ono, K; Sano, M; Shimamoto, Y; Yamaguchi, M1
Brito Barroso, ML; González Brito, G; Hernández Nieto, L; Marsá Vila, L; Raya Sánchez, JM1
Kraj, M; Maj, S; Mendek-Czajkowska, E; Pogłód, R; Rostkowska, J; Sabliński, J1
Dmoszyńska, A; Kowalewski, J; Kraj, M; Kurowska, M; Maj, S; Mendek-Czajkowska, E; Pogłód, R; Rostkowska, J; Sokołowska, B; Sokołowska, U1
Golenkov, AK1
Boyd, MA; Case, DC; Ervin, TJ; Redfield, DL1
Cuttner, J1
Baggio, G; Bolzonella, S; Casara, D; Chiarion-Sileni, V; De Besi, P; Favaretto, A; Frizzarin, M; Paccagnella, A; Salvagno, L; Soesan, M1
Barlogie, B; Beckord, J; Crowley, J; Pugh, RP; Salmon, SE1
Andriani, A; Avvisati, G; Barbui, T; Boccadoro, M; Cantonetti, M; Carotenuto, M; Comotti, B; Dammacco, F; Marmont, F; Tribalto, M1
Bartels, H; Bartl, R; Braun, HJ; Coldewey, R; Deicher, H; Fischer, JT; Gramatzki, M; Leo, R; Peest, D; von Broen, IM1
Bonnet, JD; Cheson, B; Coltman, CA; Crowley, J; Finley, P; Hutchins, LF; Milder, MS; Saeed, S; Salmon, SE; Tesh, D1
Hellquist, L; Hjorth, M; Holmberg, E; Magnusson, B; Rödjer, S; Westin, J1
Cammerer, U; Coldewey, R; Deicher, H; Hein, R; Hoffmann, L; Konyar, H; Kreuser, ED; Peest, D; Selbach, J; von Broen, IM1
Alcalá, A; Alonso, C; Besses, C; Bladé, J; García-Conde, J; Maldonado, J; Moro, MJ; San Miguel, J; Sanz Sanz, MA; Zubizarreta, A1
Factor, SM; Reed, LJ; van Hoeven, KH1
Avvisati, G; Boccadoro, M; Cantonetti, M; Cavo-Comotti, BM; Frieri, R; Gallamini, A; Gallone, G; Lauta, VM; Liberati, M; Marmont, F1
Brandwein, JM; Callum, J; Keating, A; Scott, JG; Sutcliffe, SB1
Bladé, J; Carreras, E; Cervantes, F; Grañena, A; Marín, P; Nomdedeu, B; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A1
Bartolucci, AA; Gams, RA; Kellermeyer, R; Omura, GA; Raney, M; Velez-Garcia, E1
Bukowski, RM; Montie, JE; Smith, GW1
Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN1
Binon, J; Ferrant, A; Hamoir, V; Michaux, JL; Sokal, G1
Ahre, A; Björeman, M; Björkholm, M; Brenning, G; Gahrton, G; Gyllenhammar, H; Järnmark, M; Johansson, B; Juliusson, G; Osterborg, A1
Barbui, T; Boccadoro, M; Comotti, B; Dammacco, F; Gallamini, A; Marmont, F; Neretto, G; Petrucci, MT; Pileri, A; Resegotti, L1
Schoen, HD; Wendt, T1
García Laraña, J; Odriozola, J; Pérez de Oteyza, J; Sureda, A1
Bargay, J; Besalduch, J; Galmes, A; Morey, M1
Brunner, K; Coleman, M; Cooper, MR; Cornwell, GG; Glowienka, LP; Henderson, E; Kochwa, S; McIntyre, OR; Pajak, TF; Rafla, S1
Boyd, M; Case, DC; Dorsk, BM; Hayes, DM1
Gola, A; Niewolna, M; Weryńska, B1
Bury, J; Fillet, G; Salmon, J1
Andrien, JM; Bitar, N; Bury, J; De Witte, T; Debusscher, L; Marie, JP; Peetermans, M; Solbu, G; Stryckmans, P; Suciu, S1
Anderson, J; Ezdinli, EZ; Harrington, DP; Kucuk, O; O'Connell, MJ; Silverstein, MW1
Cavo, M; Galieni, P; Gobbi, M; Tassi, C; Tura, S1
Correa Alves, A; de Andrea, ML; de Camargo, B; Franco, EL; Machado, JC1
Gomis, F; Javier Rafecas, F; Lorenzo, IJ; Martín-Aragonés, G; Martínez, JA; Marty, ML; Sanz, GF; Sanz, MA; Sayas, MJ1
Bartolucci, AA; Cohen, HJ; Forman, WB; Silberman, HR1
Gazová, S; Hrubisko, M; Prümmerová, J; Sakalová, A; Steruská, M1
Bonnet, J; Carter, S; Costanzi, JJ; Dabich, L; Dixon, DO; Durie, BG; Files, JC; Rivkin, S; Salmon, SE; Stephens, R1
Boll, J; Deicher, H; Essers, U; Gamm, H; Glück, S; Görg, K; Gramatzki, M; Peest, D; Schedel, I; Schmoll, HJ1
Bjark, P; Bondevik, A; Bull, O; Dehli, O; Kildahl-Andersen, O; Kvambe, V; Lamvik, J; Nordahl, E; Ytrehus, K1
Del Potro, E; Diaz-Mediavilla, J; Krsnik, I; Peñalver, MA1
Rosin, A; Sonnenblick, M; van Dijk, JM; Weissberg, N1
Ho, AD; Hunstein, W; Keilholz, U; Theml, H; Wittkamp, S1
Bladé, J; Cervantes, F; Feliu, E; Grañena, A; Marín, P; Montserrat, E; Nomdedeu, B; Rozman, C1
Becherer, C; Busch, FW; Ostendorf, P; Steinke, B; Waller, HD1
Anderson, JR; Davis, TE; Ezdinli, EZ; Glick, JH; Melvin, F; O'Connell, MJ1
Blanco, L; Montalbán, C; Sabán, J; Serrano Ríos, M; Serrano, M; Sevilla, F; Zapatero, A1
Bove, L; Carroll, RJ; Case, DC; Dorsk, BM; Hayes, DM; Paul, SD; Sonneborn, HL1
Boyett, J; Crist, W; Doering, EJ; Hvizdala, E; Pullen, J; Ruymann, F; Steuber, CP; Sullivan, MP; Trueworthy, R1
Bartolucci, AA; Dandy, M; Gams, RA; Omura, G; Rainey, M; Silberman, H1
Bartolucci, A; Cohen, HJ1
Amadori, S; Boccadoro, M; Cantonetti, M; Centurioni, R; Dammacco, F; Franchi, A; Papa, G; Pileri, A; Tribalto, M; Vacca, A1
Clausen, NA; Drivsholm, A; Hansen, OP; Laursen, B1
Chen, XW; Lin, TB; Lu, SF1
Cornwell, GG; Kyle, RA; Leone, L; McIntyre, OR; Pajak, TF1
Case, DC; Fanning, JP; Porensky, RS1
Carter, SK2
Carbone, PP1
Carter, SK; Goldsmith, MA1
al-Mondhiry, H; Connolly, CE; Lacher, MJ; Sahakian, GJ1
McLaren, JH; Papac, RJ1
Cheeks, JB; Laster, WR; Schabel, FM; Skipper, HE; Trader, MW1
Glidewell, O; Holland, JF1
Frei, E; Goldin, A; Schabel, FM1
Sakurai, M; Sandberg, AA1
Burchenal, JH; Clarkson, BD; Haghbin, M; Miké, V; Murphy, ML; Tan, CC1
Burchenal, JH; Clarkson, BD; Cunningham, B; Dowling, MD; Gee, TS; Haghbin, M; Tan, CT1
Lustman-Marechal, J1
Favre, E; Martz, G; Sonntag, R1
Bagley, CM; Canellos, GP; Chabner, BA; De Vita, VT; Schein, PJ; Young, RC1
Aungst, CW1
Carbone, PP; DeVita, VT1
Pruzanski, W; Saito, S1
Carter, SK; Livingston, RB1
Brunner, KW; Maurice, P; Sonntag, RW1
Glidewell, OJ; Holland, JF; Nissen, NI; Stutzman, L1
Lenhard, RE1
Jensen, KB; Nordentoft, AM1
Lewis, MB; Nunes, LB; Powell, DE; Shnider, BI1
Rubin, P1
DeVita, VT1
Senn, HJ1
Clarkson, BD; Krakoff, IH; Lee, BJ; Sahakian, G1
Fairley, GH1
Ahmann, DL; Bisel, HF; Hahn, RG1
Ahmann, DL1
Anderson, JR; Bakemeier, RF; Berard, CW; Costello, W; DeVita, VT; Glick, JH; Hines, JD; Horton, J; Rosner, G1
Portlock, CS1
Bloomfield, CD; Coleman, M; Glicksman, AS; Glidewell, OJ; Gottlieb, AJ; Holland, JF; Nissen, NI; Pajak, TF; Rafla, S; Stutzman, L; Vinciguerra, V1
Alexanian, R; Bonnet, JD; Dixon, DO; Haut, A; Salmon, SE1
deKernion, JB; Lindner, A1
Barnes, JM; Berard, CW; Costello, WG; Ezdinli, EZ; Glick, JH; Johnson, GJ; Lenhard, RE; Oken, MM; Orlow, E1
Chang, CH; Horton, J; Kramer, S; Nelson, JS; Perez-Tamayo, R; Salazer, O; Schoenfeld, D; Tsukada, Y; Weinstein, A1
Alexanian, R; Dreicer, R1
Gartenhaus, W; Jagathambal, K; Phillips, E; Rai, KR; Sawitsky, A1
Gomez, GA; Han, T; Henderson, ES; Ozer, H; Panahon, AM; Stutzman, L1
Bunn, PA; Carney, DN; Cohen, MH; Eddy, JL; Ihde, DC; Minna, JD; Morstyn, G; Schechter, GP1
Adelstein, DJ; Herzig, RH; Lazarus, HM; Smith, MC1
McLeod, BC; Sassetti, RJ; Viernes, AL1
Bartolucci, AA; Cohen, HJ; Silberman, HR; Tornyos, K1
Anderson, P; DiBella, NJ; Fink, K; Garfield, D; Murphy, J; Speer, J1
Katakkar, SB; Torrey, JJ1
Grussendorf, M; Ritz, E; Seelig, HP; Waldherr, R1
Case, DC4
Busch, FW; Ostendorf, P; Stapelfeld, S; Steinke, B; Waller, HD1
Bauer, K; Bettelheim, P; Gössinger, H; Hinterberger, W; Korninger, K; Lechner, K; Neumann, E; Niessner, H; Pabinger-Fasching, I1
Iwata, Y; Kageyama, S; Kamio, N; Karitani, Y; Kataoka, Y; Katayama, N; Kobayashi, T; Ohno, T; Ohota, C; Tanaka, I1
Blanco, L; García Laraña, J; Montalbán, C; Odriozola, J; Sevilla, F; Zapatero, A1
Benoit, Y; Bury, J; Delbeke, MJ; Fière, D; Otten, J; Solbu, G; Stryckmans, PA; Suciu, S1
Bartolucci, AA; Durant, JR; Gams, RA; Liu, C1
Bolzonella, S; Cartei, G; Chiarion Sileni, V; Fiorentino, MV; Fosser, V; Paccagnella, A; Salvagno, L1
Al-Mondhiry, H; Arlin, Z; Clarkson, B; Dowling, M; Gee, T; Hecht, S; Kempin, S; Koziner, B; Lee, BJ; Little, C; Mayer, K; Phillips, E; Reich, L; Straus, D; Thaler, HT1
Carbone, A; Crivellari, D; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A1
Boyett, JM; Duncan, MH; Dyment, PG; Falletta, JM; Humphrey, GB; Land, VJ; Pullen, DJ; Starling, KA; Sullivan, MP; Vats, T1
Vogel, CL1
Barnes, JM; Bennett, JM; Berard, CW; Ezdinli, EZ; Glick, JH; Orlow, EL1
Kilian, Z; Kołakowski, L; Kraj, M; Maj, S; Mariańska, B; Mendek, E; Rostkowska, J; Roszkowski, S; Snigurowicz, J1
Arcese, W; Colombo, R; Franchii, A; Pastore, S; Tribalto, M1
Broun, GO; Cohen, HJ; Hiramoto, RN; Petruska, PJ1
Bakemeier, RF; Barnes, JM; Bennett, JM; Costello, W; Glick, JH; Neiman, RS; Orlow, EL; Prosnitz, LR1
Bartolucci, AA; Durant, JR; Gams, RA1
Alexanian, R; Amare, M; Bonnet, J; Bottomley, R; Dixon, D; Haut, A; Salmon, S1
Abramson, N; Bennett, JM; Horton, J; Lurie, P; Mietlowski, WL; Schilling, A1
Brunner, K; Henderson, ES; Henry, PH; Holland, JF; Kyle, RA; McIntyre, OR; Nawabi, IU; Pajak, TF1
Brunner, K; Cooper, MR; Cornwell, GG; Cuttner, J; Glowienka, LP; Haurani, FI; Henderson, E; Kochwa, S; Kyle, RA; McIntyre, OR; Pajak, TF; Rafla, S; Silver, RT1
Falkson, G; Falkson, HC1
Bataille, R; Blotman, F; Bussière, JL; Ciurana, AJ; Lopitaux, R; Morlock, G; Rampon, S; Rosenberg, F; Sany, J; Serre, H; Simon, L1
Alonso, C; Badia, JM; Brunet, J; Delgado, E; Fuentes, J; Lacasta, A; Llanos, M; Mendoza, LA; Ojeda, B1
Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK1
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ1
Dommann-Scherrer, C; Honegger, HP; Jacky, E; Jost, LM; Maurer, R; Sauter, C; Stahel, RA1
Fernández, P; García, MC; Gil, MT; Rivas, C; Roldán, V1
Dreger, P; Haferlach, T; Klöss, M; Loeffler, M; Löffler, H; Petersen, B; Schmitz, N1
Bastion, Y; Brice, P; Coiffier, B; Espinouse, D; Gisselbrecht, C; Haioun, C; Marolleau, JP; Reyes, F; Salles, G; Sonet, A1
Feugier, P; Guerci, AP; Guerci, O; Guillemin, F; Péré, P; Pourel, J1
Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W1
Bartels, H; Bartl, R; Braun, HJ; Coldewey, R; Deicher, H; Fett, W; Fischer, JT; Göbel, B; Leo, R; Peest, D1
Bolwell, B; Kalaycioglu, M; Kavuru, M; Tuason, L1
Colović, MD; Janković, GM; Miletić, VD; Nikolov, VS; Suvajdzić, ND1
Brice, P; Castaigne, S; Gisselbrecht, C; Marolleau, JP; Pautier, P1
Barlogie, B; Crowley, JJ; Finley, P; Grogan, TM; Pugh, RP; Salmon, SE1
Benboubker, L; Colombat, P; Combe, M; Delain, M; Goupille, P; Lamagnère, JP; Linassier, C; Luthier, F; Petitdidier, C; Reisenleiter, M1
Albright, AL; Allen, JC; Boyett, JM; Finlay, JL; Geyer, JR; Milstein, JM; Rorke, LB; Stanley, P; Wisoff, JH; Zeltzer, PM1
Bapat, A; Goldberg, J; Goldman, N; Gordon, R; Gryn, J1
Gola, A; Kotlarek-Haus, S; Urbaniak-Kujda, D; Usnarska-Zubkiewicz, L; Wołowiec, D1
Ashkenazi, Y; Gottschalk-Sabag, S; Hershko, C; Meerkin, D1
Bergeron, C; Chatel, M; Darcel, F; Edan, C; Faivre, J; Jouan, H; Le Moine, P; Le Prise-Fleury, E; Patte, C; Tass, P1
Alcalá, A; Alonso, C; Besalduch, J; Bladé, J; García-Conde, J; Maldonado, J; Moro, MJ; San Miguel, JF; Sanz, MA; Zubizarreta, A1
Baczyński, S; Kuliszkiewicz-Janus, M1
Elonen, E; Jokipii, A; Lautenschlager, I; Lyytikäinen, O; Ruutu, P; Tiittanen, L1
Crowley, J; Modiano, MR; Salmon, SE; Villar-Werstler, P1
Calabresi, F; De Sanctis, V; Fiacchini, M; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Meloni, G; Papa, G; Tura, S; Vignetti, M; Zinzani, PL1
Attal, M; Bataille, R; Casassus, P; Facon, T; Fuzibet, JG; Harousseau, JL; Ifrah, N; Maisonneuve, H; Payen, C; Rossi, JF; Sotto, JJ; Stoppa, AM1
Bonini, A; Carotenuto, M; Cascavilla, N; D'Arena, G; Di Mauro, L; Greco, MM; Melillo, L; Minervini, MM; Musto, P; Sajeva, MR; Scalzulli, P1
Haynes, AP; Iqbal, A; McQuaker, IG; Russell, NH1
Gregory, SA; Greipp, PR; Kay, NE; Kyle, RA; O'Connell M, J; Oken, MM; Spiegel R, J; Tsiatis, A1
Billadeau, D; Greipp, P; Kay, NE; Kyle, RA; Leong, T; Liu, P; Oken, MM; Quam, L; Van Ness, B1
Alcalá, A; Besses, C; Bladé, J; Estapé, J; Fontanillas, M; García-Conde, J; Maldonado, J; Montserrat, E; Moro, MJ; Muñoz, M; Rozman, C; San Miguel, J1
Argentino, C; Avvisati, G; Boccadoro, M; Comotti, B; Dominietto, A; Frieri, R; Lauta, VM; Liberati, M; Marmont, F; Musto, P; Palumbo, A; Pileri, A; Tribalto, M1
Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R1
Barbui, T; Bertini, M; Botto, B; Cinieri, S; Cortellazzo, S; Falda, M; Freilone, R; Grignani, F; Levis, A; Liberati, AM; Locatelli, F; Lovisone, E; Marmont, F; Pizzuti, M; Resegotti, L; Rossi, A; Viero, P; Vitolo, U1
Attal, M; Harousseau, JL2
Keimowitz, RM1
Abramson, N; Glick, JH; Harrington, DP; Knospe, W; Kyle, RA; Oken, MM1
Bradstock, K; Gibson, J; Goldstein, D; Joshua, DE; Laidlaw, CR; Matthews, JP; Penny, R; Wolf, M1
Baccarani, M; Barillari, G; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Rinaldi, C; Savignano, C; Silvestri, F; Zaja, F1
Antonijevic, N; Colovic, M; Jovanovic, V; Radosevic-Radojkovic, N; Rolovic, Z1
Anderson, L; Linch, DC; Vaughan Hudson, B; Vaughan Hudson, G1
Capria, S; Mandelli, F; Meloni, G; Modena, V; Vignetti, M1
Barbui, T; Bellavita, P; Cortelazzo, S; Marchioli, R; Marfisi, RM; Rambaldi, A; Rossi, A; Viero, P1
Chap, L; Glaspy, J; Levine, M; Lill, M; Norton, L; Shpiner, R1
Dmoszyńska, A; Sokołowska, B; Walter-Croneck, A; Wojtaszko, M1
Azaceta, G; Palomera, L; Soria, J; Varo, MJ1
Dreger, P; Glass, B; Kuse, R; Löffler, H; Schmitz, N; Schoch, R; Sonnen, R; Uharek, L; von Neuhoff, N1
Arias, J; Besalduch, J; Bladé, J; Carnero, M; Escudero, ML; Estapé, J; Fontanillas, M; García-Conde, J; Gardella, S; Marti, JM; Montserrat, E; Rozman, C; San Miguel, JF1
Bulabois, CE; Colombat, P; Dupas, B; Harousseau, JL; Juge-Morineau, N; Mahé, B; Milpied, N; Moreau, A; Moreau, P; Rapp, MJ; Voillat, L1
Cunningham, D; Popescu, RA; Wotherspoon, AC1
Ackermann, J; DeSantis, M; Drach, J; Fiegl, M; Fritz, E; Gisslinger, H; Heinz, R; Huber, H; Krömer, E; Ludwig, H; Roka, S; Schuster, J; Schuster, R; Zojer, N1
Usnarska-Zubkiewicz, L1
Buschfort, C; Lensing, C; Müller, MR; Rajewsky, MF; Seeber, S; Thomale, J1
Azais, I; Bernard, JF; De Gramont, A; Doyen, C; Euller-Ziegler, L; Grosbois, B; Laporte, JP; Le Loët, X; Ménard, JF; Michaux, JL; Mineur, P; Monconduit, M; Peny, AM; Pollet, JP; Wetterwald, M1
Colović, MD; Colović, RB; Janković, GM; Martinović-Cemerikić, VM1
Chen, MG; Gastineau, DA; Gertz, MA; Greipp, PR; Inwards, DJ; Kyle, RA; Lacy, MQ; Litzow, MR; Lust, JA; Pineda, AA; Tefferi, A; Witzig, TE1
Dispenzieri, A; Gertz, MA; Lacy, MQ1
Gertz, MA; Greipp, PR; Kyle, RA; Lacy, MQ; Lust, JA; Witzig, TE1
Biriukova, LS; Fetisova, EV; Margolin, OV; Pivnik, AV; Volodiaeva, EB1
Greipp, PR; Kay, NE; Keimowitz, RM; Kyle, RA; Lenhard, RE; Leong, T; Oken, MM; Van Ness, B1
Calabuig Alborch, JR; García Gascó, P; Micó Giner, L; Sanchis-Bayarri Bernal, V; Tordera Higón, P1
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D1
Korfel, A; Krackhardt, A; Schwartz, S; Thiel, E1
Foss, HD; Keilholz, U; Knauf, W; Siehl, J; Szelényi, H; Thiel, E1
Buijt, I; Huijgens, PC; Ossenkoppele, GJ; Uyl-de Groot, CA1
Blume, KG; Cao, TM; Hu, WW; Johnston, LJ; Negrin, RS; Rizk, NW; Shizuru, JA; Stockerl-Goldstein, KE; Taylor, TL; Wong, RM1
Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O1
Dobie, D; Hastings, M; Mahendra, P; Richardson, G; Tauro, S1
Anagnostopoulos, N; Barbarousi, D; Bourantas, K; Dimopoulos, MA; Gregoraki, B; Maniatis, A; Pouli, A; Tzilianos, M; Venetis, E; Vyniou, N; Zervas, K1
Weiss, M1
Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A1
Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J1
Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K1
Ariatti, C; Bertini, M; Boccomini, C; Botto, B; Calvi, R; Capello, D; Carbone, A; Freilone, R; Gaidano, G; Gallo, E; Gloghini, A; Milan, I; Novero, D; Orsucci, L; Palestro, G; Parvis, G; Pregno, P; Saglio, G; Vitolo, U; Vivenza, D; Zagonel, V1
Dreger, P; Glass, B; Haas, R; Kneba, M; Kröger, N; Kuse, R; Martin, S; Parwaresch, R; Schmitz, N; Sonnen, R1
Barbui, T; Bassan, R; Carter, M; Casula, P; Di Bona, E; Fabris, P; Lambertenghi-Deliliers, G; Lerede, T; Lister, TA; Morandi, S; Pogliani, E; Rambaldi, A; Rohatiner, AZ; Rossi, G1
Gallagher, M; Garban, F; Jacob, MC; Jouvin-Marche, E; Marche, PN; Moine, A; Sotto, JJ1
Alcalá, A; Besalduch, J; Besses, C; Bladé, J; Brunet, S; Carbonell, F; Carnero, M; Conde, E; Escudero, ML; Estapé, J; Esteve, J; Fernández-Calvo, J; Font, L; Fontanillas, M; García-Conde, J; Gardella, S; Hernández-Martín, J; Maldonado, J; Martí, JM; Montserrat, E; Moro, MJ; Ortega, F; Ribera, JM; Rozman, C; San Miguel, JF; Trujillo, J1
Cook, W; Listinsky, CM; Thompson, KA; Vannucci, SA; Volk, AL1
Clemente González, C; García Parés, D; García-Bragado Dalmau, F; Guardia Sánchez, R; Pérez Ayuso, MJ; Porcar Ramells, C1
Elonen, E; Franssila, K; Itälä, M; Jantunen, E; Kuittinen, O; Lehtinen, T; Oinonen, R; Wiklund, T1
Bataille, R; Harousseau, JL; Mahé, B; Milpied, N; Misbahi, R; Moreau, P; Morineau, N; Rapp, MJ; Vigier, M1
Albó, C; Arranz, R; Caballero, MD; Cabrera, R; Carreras, E; Conde, E; Fernández de Sevilla, A; Gandarillas, M; García Ruíz, JC; García-Conde, J; García-Laraña, J; Grande, C; Iriondo, A; Lahuerta, JJ; Marín, J; Moraleda, JM; Pérez-Equiza, C; Pérez-Simón, JA; Rifón, J; Rubio, V; San Miguel, JF; Sierra, J; Sureda, A; Varela, R; Vidal, MJ; Zuazu, J1
Afanas'ev, BV; Alekseeva, IuA; Medvedeva, NV; Mikhaĭlova, NB; Zaritskiĭ, AIu; Zubarovskaia, LS2
Dai, MS; Hou, TY; Kao, WY1
Mead, G; Woodcock, J; Young, C1
Barnes, C; Blanchette, V; Canning, P; Greenberg, M; Price, V1
Rao, PS1
Barez, A; Bladé, J; Callís, M; Carbonell, F; Díaz-Mediavilla, J; Fernández-Calvo, J; Font, L; Fontanillas, M; García-Laraña, J; Gardella, S; Giraldo, P; Martí, JM; Mateos, MV; Moro, MJ; Palomera, L; Ribera, JM; Rosiñol, L; San Miguel, J; Soler, A; Sureda, A; Trujillo, J1
Bauchmüller, K; Engelhardt, M; Schmitt-Gräff, A; Strobel, ES1
Anderson, KC; Barlogie, B; Chapman, RA; Cromer, JN; Crowley, JC; Dakhil, SR; Durie, B; Greipp, PR; Hurd, DD; Kyle, RA; Lanier, KS; Lazarus, HM; McCoy, J; Moore, DF; Salmon, SE1
Bahlis, N; Balogh, A; Brown, C; Jones, A; Morris, DG; Russell, JA; Savoie, L; Stewart, DA; Valentine, K1
Greipp, PR; Kay, NE; Kyle, RA; Leong, T; Li, S; Oken, MM; Van Ness, B1
Alcalá, A; Alegre, A; Besalduch, J; Bladé, J; Carrera, D; Casado, LF; de Arriba, F; de la Rubia, J; Fernández, P; García Boyero, R; García, PR; García-Laraña, J; Hernández, MT; Lahuerta, JJ; Martínez, R; Palomera Bernal, L; Pérez-Calvo, J; Ribera, JM; San Miguel, J; Sureda, A1
Aldouri, M; Devereux, S; Milojković, D; Mufti, GJ; Pagliuca, A1
Dörken, B; Dreyling, M; Forstpointner, R; Freund, M; Ganser, A; Hiddemann, W; Hoster, E; Huber, C; Ludwig, WD; Nickenig, C; Trümper, L; Unterhalt, M1
Arceci, RJ; Chen, AR; Colombani, P; Higman, MA; Schwartz, CL; Wharam, M; Williams, KM1
Meng, H; Qian, W; Shao, K; Yang, C; Yang, X; Ye, X; Zhou, Y1
Al-Ali, HK; Niederwieser, D; Wittekind, C1
Albo, C; Alonso, N; Arranz, R; Caballero, D; Conde, E; Fernández-Rañada, JM; Gandarillas, M; García Vela, JA; Garzón, S; Grande, C; Hernández, MT; Lahuerta, JJ; Mateos, MV; Rodríguez, J1
Briones, J; Camós, M; Colomo, L; Escoda, L; Espinosa, I; Estany, C; Gutiérrez-García, G; López-Guillermo, A; Martínez, S; Martino, R; Mercadal, S; Montserrat, E; Pedro, C; Ribera, JM; Xicoy, B1
Friedenberg, WR; Greipp, PR; Jacobus, S; Kyle, RA; Rajkumar, SV; Slabber, CF1
Bahlis, N; Mansoor, A; Stewart, DA1
Domm, J; Eckrich, MJ; Frangoul, H; Ho, R; Whitlock, JA1
García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L1
Kuruvilla, J1
Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J1
Aarden, L; Baars, JW; Beijnen, JH; Huitema, AD; Tran, L1
Bartlett, NL; Cashen, AF; Foyil, KV; Grove, LE; Kennedy, DA1
Ma, X; Ren, C; Sheng, Z; Wang, B; Xia, B; Zhang, W1
Angelopoulou, MK; Beris, P; Constantinou, N; Dervenoulas, J; Diamantopoulos, P; Dimopoulos, MA; Dimou, M; Economopoulou, C; Economopoulou, P; Efthimiou, A; Georgiou, G; Kalpadakis, C; Katsigiannis, A; Korkolopoulou, P; Kotsianidis, I; Kyrtsonis, MC; Levidou, G; Meletis, J; Panayiotidis, P; Pangalis, GA; Papageorgiou, SG; Pappa, V; Tsirigotis, P; Vassilakopoulos, TP1
Aznar Oroval, E; García-Lozano, T; Juan Bañón, JL; Lorente Alegre, P1
Beuthien-Baumann, B; Bornhäuser, M; Ehninger, G; Kroschinsky, F; Middeke, JM; Ordemann, R; Platzbecker, U; Platzek, I; Stöhlmacher, J; van den Hoff, J; Zietz, C1
Barboza, R; Coelho, BM; Guerra, JL; Lucas, SR; Maranhão, RC; Pozzi, DH1
Belada, D; Berková, A; Bolomská, I; Burešová, L; Campr, V; Klener, P; Kozák, T; Kubáčková, K; Matuška, M; Pirnos, J; Přibylová, J; Pytlík, R; Sýkorová, A; Trněný, M; Vášová, I1
Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A1
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A1
Arranz, R; Bargay, J; Bello, JL; Caballero, MD; Conde, E; Coronado, M; González-Barca, E; Grande, C; Hernández, MT; Marín-Niebla, A; Martín, A; Montes-Moreno, S; Panizo, C; Pardal, E; Pérez-Ceballos, E1
Ancochea, Á; Fernández-Rodriguez, C; García-Pallarols, F; Gimeno, E; Salar, A; Sánchez-González, B1
Nagai, H1
Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A1
Ahn, HS; Hong, CR; Kang, HJ; Park, KD; Shin, HY1
Braziel, RM; Chansky, K; Chen, AI; Dunlap, JB; Fan, G; Gay, ND; Leonard, JT; Maziarz, RT; Okada, CY; Raess, PW; Stentz, A1
Beeker, A; Berenschot, HW; Bilgin, YM; Böhmer, LH; Brouwer, RE; Chiţu, D; de Jong, D; Doorduijn, JK; Herbers, AHE; Hijmering, N; Hoogendoorn, M; Kersten, MJ; Koene, HR; Lam, KH; Lugtenburg, PJ; Schouten, HC; van der Burg-de Graauw, NC; van Imhoff, GW; Zijlstra, JM1
Arora, R; Hildebrandt, GC; Munker, R; Qasrawi, A; Ramlal, R1
Böhmer, LH; Chitu, DA; de Jong, D; de Jongh, E; de Weerdt, O; Doorduijn, JK; Hoogendoorn, M; Kersten, MJ; Kibbelaar, RE; Kluin-Nelemans, HC; Leys, RBL; Lugtenburg, PJ; MacKenzie, MA; Minnema, MC; Snijders, TJF; van Gelder, M; van Marwijk Kooij, R; Van't Veer, MB; Zijlstra, JM1
Charifa, A; Ko, CJ; Lee, A; Levy, L; McNiff, JM; Paulson, N; Perincheri, S1
Duell, J; Einsele, H; Gerhard-Hartmann, E; Heidemeier, A; Krummenast, FC; Rosenwald, A; Steinhardt, MJ; Topp, MS1
Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P1

Reviews

29 review(s) available for prednisone and carmustine

ArticleYear
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Cancer treatment reports, 1977, Volume: 61, Issue:6

    Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine

1977
[Treatment of Kahler's disease].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1976, Jan-16, Volume: 52, Issue:3

    Topics: Bone Neoplasms; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Prednisone; Procarbazine; Urethane; Vincristine

1976
[Recent progress in chemotherapy of multiple myeloma].
    Recenti progressi in medicina, 1978, Volume: 65, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine

1978
Current concepts in cancer. Multiple myeloma.
    The New England journal of medicine, 1979, Jul-26, Volume: 301, Issue:4

    Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunoglobulins; Lomustine; Melphalan; Multiple Myeloma; Neoplasm Staging; Plasmapheresis; Prednisone; Risk; Sodium Fluoride; Uremia

1979
The treatment of plasma cell myeloma.
    British journal of haematology, 1976, Volume: 33, Issue:4

    Topics: Animals; Carmustine; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Humans; Melphalan; Methotrexate; Mice; Mice, Inbred BALB C; Multiple Myeloma; Myeloma Proteins; Prednisone; Procarbazine; Remission, Spontaneous

1976
[Treatment of relapses and failures in disseminated Hodgkin's disease].
    Presse medicale (Paris, France : 1983), 1991, Nov-02, Volume: 20, Issue:35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine

1991
[Chemotherapy of multiple myeloma].
    Sovetskaia meditsina, 1991, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Drug Evaluation; Humans; Melphalan; Multiple Myeloma; Prednisone; Remission Induction; Vincristine

1991
Current status of new agents.
    Cancer chemotherapy reports. Part 3, 1972, Volume: 3, Issue:1

    Topics: Alopecia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Azaguanine; Carmustine; Cyclohexanes; Drug Combinations; Heart; Humans; Leukemia L1210; Nitrosourea Compounds; Platinum; Prednisone; Remission, Spontaneous

1972
Combination chemotherapy of advanced Hodgkin's disease. A review.
    Cancer, 1974, Volume: 33, Issue:1

    Topics: Bleomycin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Italy; Mechlorethamine; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; United States; Vinblastine; Vincristine

1974
Plasma cell myeloma. An interpretive review.
    Cancer, 1972, Volume: 30, Issue:6

    Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Carmustine; Cell Division; Cyclophosphamide; Drug Resistance; Humans; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous

1972
An overview of the status of the nitrosoureas in other tumors.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:3

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Melanoma; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Vincristine

1973
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    Proceedings. National Cancer Conference, 1972, Volume: 7

    Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vinca Alkaloids; Vincristine

1972
Current chemotherapeutic combinations.
    Series haematologica (1968), 1973, Volume: 6, Issue:2

    Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Time Factors; Vinblastine; Vincristine

1973
Single-agent therapy for Hodgkin's disease.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclophosphamide; Dactinomycin; Evaluation Studies as Topic; Fluorouracil; Hodgkin Disease; Humans; Mechlorethamine; Mercaptopurine; Methotrexate; Prednisone; Procarbazine; Thiotepa; Vinblastine; Vincristine

1973
Combination chemotherapy in malignant diseases.
    Journal of the Royal College of Physicians of London, 1971, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosine; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Immunotherapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine

1971
Chemotherapy of hormonally unresponsive prostatic carcinoma.
    The Urologic clinics of North America, 1984, Volume: 11, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine

1984
Chronic lymphocytic leukemia.
    The Medical clinics of North America, 1984, Volume: 68, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carmustine; Chromosomes, Human, 6-12 and X; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Lymphoid; Male; Melphalan; Middle Aged; Neoplasm Staging; Prednisone; T-Lymphocytes; Trisomy; Vincristine

1984
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).
    Blood, 1982, Volume: 60, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Femur Head Necrosis; Humans; Hypercalcemia; Leukemia, Lymphoid; Male; Melphalan; Neoplasms, Multiple Primary; Paresthesia; Prednisone; Prognosis; Thrombocytopenia; Vincristine

1982
Management of Kaposi's sarcoma. Chemotherapy I.
    Antibiotics and chemotherapy, 1981, Volume: 29

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Carmustine; Dactinomycin; Humans; Immunosuppressive Agents; Prednisone; Razoxane; Sarcoma, Kaposi; Vinca Alkaloids

1981
[Chemotherapy of multiple myeloma. Review of the recent trials].
    Recenti progressi in medicina, 1981, Volume: 71, Issue:2

    Topics: Antineoplastic Agents; Azathioprine; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Prednisone; Procarbazine; Vincristine

1981
Plasma cell dyscrasia with marrow fibrosis. A reversible syndrome mimicking agnogenic myeloid metaplasia.
    Cancer, 1994, Feb-01, Volume: 73, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Paraproteinemias; Prednisone; Primary Myelofibrosis; Splenomegaly; Vincristine

1994
Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Carmustine; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasms, Second Primary; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine

1993
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
    Hematology/oncology clinics of North America, 2001, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine

2001
[Primary cardiac lymphoma: cytological diagnosis and treatment with response to polychemotherapy and hematopoietic precursor autotransplant. Presentation of a case a review of the literature].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Atrial Flutter; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Echocardiography, Transesophageal; Etoposide; Heart Failure; Heart Neoplasms; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Immunocompetence; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Middle Aged; Pleural Effusion; Prednisone; Remission Induction; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Vincristine

2002
Autologous stem cell transplantation in patients with mantle cell lymphoma.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:6

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Finland; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Life Tables; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2002
Non-hodgkins lymphoma.
    Clinical evidence, 2003, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Idarubicin; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Prednisone; Vincristine

2003
Standard therapy of advanced Hodgkin lymphoma.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2009
Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.
    Hematological oncology, 2013, Volume: 31, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Prednisone; Recombinant Proteins; Remission Induction; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation

2013
[Treatment strategy of Hodgkin lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Mechlorethamine; Melphalan; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Rituximab; Vinblastine; Vincristine

2014

Trials

124 trial(s) available for prednisone and carmustine

ArticleYear
Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
    Cancer treatment reports, 1976, Volume: 60, Issue:6

    Topics: Bleomycin; Carmustine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Prednisone; Procarbazine; Prospective Studies; Vincristine

1976
Multiple agent chemotherapy for advanced histiocytic lymphoma.
    European journal of cancer, 1976, Volume: 12, Issue:5

    Topics: Adult; Aged; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Middle Aged; Prednisone; Vincristine

1976
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Cancer treatment reports, 1977, Volume: 61, Issue:6

    Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine

1977
Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial.
    International journal of clinical pharmacology and biopharmacy, 1978, Volume: 16, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lung Neoplasms; Middle Aged; Prednisone; Vincristine

1978
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
    Cancer, 1978, Volume: 41, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Lymphoid; Lomustine; Male; Prednisone; Recurrence; Remission, Spontaneous; Vincristine

1978
Primary treatment of disseminated Hodgkin's disease with BCNU alone and in combination with vincristine, procarbazine, and prednisone.
    Cancer treatment reports, 1977, Volume: 61, Issue:5

    Topics: Adult; Blood Cell Count; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Time Factors; Vincristine

1977
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Cancer treatment reports, 1977, Volume: 61, Issue:6

    Topics: Carmustine; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine

1977
Treatment of histiocytic and mixed lymphomas: a comparison of two, three and four drug chemotherapy.
    Cancer, 1978, Volume: 42, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine

1978
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
    Cancer, 1979, Volume: 43, Issue:1

    Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine

1979
Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGB.
    Blood, 1979, Volume: 54, Issue:1

    Topics: Alkylating Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Leukopenia; Melphalan; Multiple Myeloma; Prednisone; Prognosis

1979
Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNU.
    Cancer treatment reports, 1979, Volume: 63, Issue:8

    Topics: Carmustine; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Prednisone

1979
The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia.
    The New England journal of medicine, 1979, 10-04, Volume: 301, Issue:14

    Topics: Acute Disease; Adult; Aged; Alkylating Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunoglobulins; Leukemia; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Prospective Studies; Risk

1979
Combination therapy for multiple myeloma.
    Cancer, 1977, Volume: 40, Issue:6

    Topics: Antineoplastic Agents; Azathioprine; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Multiple Myeloma; Prednisone; Remission, Spontaneous; Time Factors; Vincristine

1977
BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
    Cancer, 1978, Volume: 42, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Time Factors; Vinblastine

1978
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
    Cancer treatment reports, 1976, Volume: 60, Issue:6

    Topics: Administration, Oral; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Nitrosourea Compounds; Prednisone; Procarbazine; Semustine; Vinblastine

1976
Nitrosoureas in multiple myeloma.
    Cancer treatment reports, 1976, Volume: 60, Issue:6

    Topics: Carmustine; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Lomustine; Multiple Myeloma; Neoplasm Recurrence, Local; Nitrosourea Compounds; Prednisone; Remission, Spontaneous

1976
Lymphosarcoma. A comparison of extended to conservative chemotherapy.
    Cancer, 1976, Volume: 37, Issue:3

    Topics: Adult; Aged; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Remission, Spontaneous; Vincristine

1976
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.
    Biometrics, 1975, Volume: 31, Issue:1

    Topics: Carmustine; Clinical Trials as Topic; Cyclophosphamide; Evaluation Studies as Topic; Humans; Lymphoma; Models, Theoretical; Prednisone; Prognosis; Statistics as Topic; Vincristine

1975
Remission maintenance therapy for multiple myeloma.
    Archives of internal medicine, 1975, Volume: 135, Issue:1

    Topics: Bone Neoplasms; Carmustine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Recurrence; Remission, Spontaneous; Time Factors; Vincristine

1975
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
    Acta clinica Belgica, 1992, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mitoguazone; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vinblastine; Vincristine

1992
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM).
    British journal of haematology, 1992, Volume: 80, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Vincristine

1992
[Therapeutic plasmapheresis in patients with multiple myeloma].
    Acta haematologica Polonica, 1991, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Plasmapheresis; Prednisone; Vincristine

1991
[Chemotherapy and immunomodulating treatment of patients with multiple myeloma].
    Acta haematologica Polonica, 1991, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon-alpha; Levamisole; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Remission Induction; Thymus Extracts; Vincristine

1991
Waldenström's macroglobulinemia: long-term results with the M-2 protocol.
    Cancer investigation, 1991, Volume: 9, Issue:1

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Administration Schedule; Humans; Leukopenia; Melphalan; Nausea; Prednisone; Vincristine; Vomiting; Waldenstrom Macroglobulinemia

1991
Second and third responses to the same induction regimen in relapsing patients with multiple myeloma.
    Cancer, 1991, Sep-01, Volume: 68, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1991
alpha-Interferon for remission maintenance: preliminary report on the Southwest Oncology Group Study.
    Seminars in oncology, 1991, Volume: 18, Issue:5 Suppl 7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Humans; Interferon-alpha; Melphalan; Multiple Myeloma; Prednisone; Remission Induction; Vincristine

1991
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Vincristine

1991
Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatmen
    Onkologie, 1990, Volume: 13, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Dexamethasone; Doxorubicin; Female; Humans; Interferon Type I; Male; Melphalan; Multiple Myeloma; Neoplasm Staging; Prednisone; Recombinant Proteins; Vincristine

1990
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers, Tumor; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Vincristine

1990
Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. The Myeloma Group of Western Sweden.
    British journal of haematology, 1990, Volume: 74, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Vincristine

1990
Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAMDex) therapy for multiple myeloma. Early results of a multicenter trial. The German Myeloma Treatment Group.
    Onkologie, 1990, Volume: 13, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Melphalan; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Prednisone; Vincristine

1990
A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myeloma.
    Blut, 1990, Volume: 60, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Melphalan; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Vincristine

1990
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Sangre, 1990, Volume: 35, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spain; Survival Rate; Teniposide; Thioguanine; Vincristine

1990
Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease. A Southeastern Cancer Study Group trial.
    Cancer, 1986, Nov-01, Volume: 58, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Random Allocation; Vinblastine

1986
Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms.
    Urology, 1988, Volume: 31, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Etoposide; Evaluation Studies as Topic; Follow-Up Studies; Humans; Male; Nausea; Neoplasms, Germ Cell and Embryonal; Prednisone; Prognosis; Prospective Studies; Teratoma; Testicular Neoplasms; Vinblastine; Vindesine; Vomiting

1988
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCS.
    European journal of haematology, 1989, Volume: 43, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prospective Studies; Random Allocation; Sweden; Vincristine

1989
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Cycle; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Drug Evaluation; Humans; Melphalan; Multiple Myeloma; Paraproteinemias; Plasma Cells; Prednisone; Prognosis; Random Allocation; Vincristine

1989
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Lomustine; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Random Allocation; Vincristine

1988
[Results of the combined treatment of advanced multiple myeloma by the M-2 protocol: cyclophosphamide, vincristine, melphalan, nitrosourea and prednisone].
    Polskie Archiwum Medycyny Wewnetrznej, 1987, Volume: 77, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Sclerosis; Prednisone; Vincristine

1987
The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma.
    Cancer, 1987, Jul-15, Volume: 60, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Random Allocation; Vincristine

1987
Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Melphalan; Multiple Myeloma; Prednisone; Random Allocation; Risk; Time Factors; Vincristine

1986
Results and further perspectives of plasmocytoma chemotherapy.
    Neoplasma, 1986, Volume: 33, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Humans; Melphalan; Multiple Myeloma; Prednisone; Vincristine

1986
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:8

    Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Hematologic Diseases; Humans; Levamisole; Melphalan; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Random Allocation; Vincristine

1986
Current results of a multicenter trial in multiple myeloma.
    Onkologie, 1986, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Melphalan; Multiple Myeloma; Neoplasm Staging; Prednisone; Random Allocation; Vincristine

1986
Multiple myeloma in central Norway 1981-1982: a randomized clinical trial of 5-drug combination therapy versus standard therapy.
    Scandinavian journal of haematology, 1986, Volume: 37, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Humans; Melphalan; Multiple Myeloma; Prednisone; Random Allocation; Vincristine

1986
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Random Allocation; Risk; Vincristine

1985
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Cancer, 1985, Jan-15, Volume: 55, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Thioguanine; Vincristine

1985
Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Prognosis; Regression Analysis; Vincristine

1985
Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience.
    The American journal of medicine, 1985, Volume: 79, Issue:3

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis

1985
Treatment of multiple myeloma: a randomized study of three different regimens.
    Leukemia research, 1985, Volume: 9, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Immunoglobulin A; Immunoglobulin D; Leukopenia; Male; Melphalan; Middle Aged; Multiple Myeloma; Peptichemio; Prednisone; Prognosis; Random Allocation; Vincristine

1985
Phase III study of intermittent 5-drug regimen (VBCMP) versus intermittent 3-drug regimen (VMP) versus intermittent melphalan and prednisone (MP) in myelomatosis.
    Scandinavian journal of haematology, 1985, Volume: 35, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Resistance; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1985
Response rate and survival in myeloma patients receiving prednisone alone.
    Medical and pediatric oncology, 1985, Volume: 13, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Random Allocation; Recurrence

1985
Chemotherapy of acute lymphocytic leukemia of childhood.
    Cancer, 1972, Volume: 30, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Carmustine; Cell Division; Cell Transformation, Neoplastic; Child; Child, Preschool; Daunorubicin; Humans; Infant; Infant, Newborn; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Mitosis; Prednisone; Remission, Spontaneous; Vincristine

1972
[Therapeutic experiences in multiple myeloma].
    Schweizerische medizinische Wochenschrift, 1972, Nov-04, Volume: 102, Issue:44

    Topics: Aniline Compounds; Antineoplastic Agents; Blood Sedimentation; Carmustine; Clinical Trials as Topic; Drug Synergism; Hemoglobinometry; Humans; Melphalan; Multiple Myeloma; Mustard Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous

1972
[On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Schweizerische medizinische Wochenschrift, 1972, Oct-28, Volume: 102, Issue:43

    Topics: Carmustine; Chlorambucil; Cyclohexanes; Drug Resistance; Drug Synergism; Hodgkin Disease; Humans; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Thrombocytopenia; Time Factors; Vinblastine; Vincristine

1972
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine

1973
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
    Annals of internal medicine, 1984, Volume: 101, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Peripheral Nervous System Diseases; Prednisone; Procarbazine; Random Allocation; Vinblastine; Vincristine

1984
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adult; Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Prednisone; Procarbazine; Vincristine

1982
Chemotherapy of hormonally unresponsive prostatic carcinoma.
    The Urologic clinics of North America, 1984, Volume: 11, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine

1984
Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Cancer, 1983, Sep-15, Volume: 52, Issue:6

    Topics: Adult; Age Factors; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Prednisone; Probability; Prognosis; Radiotherapy Dosage; Random Allocation; Semustine

1983
Chemotherapy for multiple myeloma.
    Cancer, 1984, Feb-01, Volume: 53, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Levamisole; Melphalan; Multiple Myeloma; Prednisone; Prognosis; Random Allocation; Vincristine

1984
Simultaneous low-dose radiation and low-dose chemotherapy in the treatment of advanced Hodgkin's disease.
    American journal of clinical oncology, 1984, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Vincristine

1984
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
    Cancer treatment reports, 1984, Volume: 68, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Staging; Prednisone; Vincristine

1984
Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma.
    Blood, 1984, Volume: 63, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium Gluconate; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Fluoxymesterone; Humans; Long-Term Care; Melphalan; Multiple Myeloma; Prednisone; Radiography; Sodium Fluoride; United States; Vitamin D

1984
[Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
    Sangre, 1984, Volume: 29, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Male; Melphalan; Multiple Myeloma; Prednisone; Vincristine

1984
Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults.
    Blood, 1983, Volume: 62, Issue:3

    Topics: Adolescent; Adult; Asparaginase; BCG Vaccine; Carmustine; Child; Child, Preschool; Cyclophosphamide; Humans; Immunotherapy; Infant; Injections, Spinal; Leukemia, Lymphoid; Lymphocyte Transfusion; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Vincristine

1983
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
    Cancer, 1983, Dec-15, Volume: 52, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Risk; Vinblastine; Vincristine

1983
Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
    Blood, 1982, Volume: 60, Issue:5

    Topics: Adolescent; Allopurinol; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Prednisone; Prognosis; Rosette Formation; T-Lymphocytes; Thioguanine; Vincristine

1982
Chemotherapy of plasma-cell myeloma.
    The New England journal of medicine, 1980, Feb-14, Volume: 302, Issue:7

    Topics: Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Prednisone; Vincristine

1980
Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy.
    Blood, 1981, Volume: 58, Issue:5

    Topics: Adult; Aged; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Procarbazine; Random Allocation; Vincristine

1981
Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Archivum immunologiae et therapiae experimentalis, 1981, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1981
Cisplatin, BCNU, cyclophosphamide, and prednisone in multiple myeloma.
    Cancer treatment reports, 1982, Volume: 66, Issue:2

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Bone Marrow; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kidney; Male; Mice; Middle Aged; Multiple Myeloma; Nausea; Prednisone; Vomiting

1982
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine

1982
Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine

1982
Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
    Cancer treatment reports, 1982, Volume: 66, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Humans; Leukocyte Count; Multiple Myeloma; Myeloma Proteins; Platelet Count; Prednisone; Prognosis; Thrombocytopenia; Vincristine

1982
Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Cancer treatment reports, 1982, Volume: 66, Issue:6

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Prospective Studies; Random Allocation

1982
Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.
    Cancer treatment reports, 1982, Volume: 66, Issue:3

    Topics: Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Humans; Leukopenia; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Random Allocation; Thrombocytopenia

1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
    Cancer, 1982, Nov-01, Volume: 50, Issue:9

    Topics: Antineoplastic Agents; Carmustine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Random Allocation; Thrombocytopenia; Vincristine

1982
Chemotherapy and radiotherapy in locally advanced cervical cancer.
    Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carmustine; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Melphalan; Middle Aged; Prednisone; Survival Rate; Uterine Cervical Neoplasms

1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
    Blood, 1995, Jul-15, Volume: 86, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Carmustine; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Transplantation, Autologous; Vincristine

1995
Development of a criterion for response to therapy at 6 months in multiple myeloma.
    European journal of haematology, 1995, Volume: 55, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Immunoglobulin A; Immunoglobulin G; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Survival Rate; Vincristine

1995
A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Dexamethasone; Doxorubicin; Female; Humans; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Vincristine

1995
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Glucocorticoids; Humans; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Remission Induction; Survival Analysis; Vincristine

1994
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Regression Analysis; Survival Analysis; Treatment Outcome; Vincristine; Vindesine

1994
Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Survival Rate; Vincristine

1993
Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Black People; Carmustine; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Retrospective Studies; Survival Analysis; Vincristine; White People

1996
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter s
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Vincristine

1996
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.
    The New England journal of medicine, 1996, Jul-11, Volume: 335, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Multivariate Analysis; Prednisone; Prospective Studies; Salvage Therapy; Survival Analysis; Vincristine

1996
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
    Leukemia & lymphoma, 1996, Volume: 20, Issue:5-6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Male; Melphalan; Middle Aged; Multiple Myeloma; Myocardial Infarction; Neutropenia; Prednisone; Recombinant Proteins; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine

1996
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.
    Blood, 1996, Oct-01, Volume: 88, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Clone Cells; Codon; Combined Modality Therapy; Cyclophosphamide; Disease Progression; DNA Mutational Analysis; DNA, Neoplasm; Female; Genes, ras; Humans; Immunologic Factors; Interferon-alpha; Life Tables; Male; Melphalan; Middle Aged; Multiple Myeloma; Polymorphism, Restriction Fragment Length; Prednisone; Prognosis; Survival Analysis; Vincristine

1996
Treatment of multiple myeloma in elderly people: long-term results in 178 patients.
    Age and ageing, 1996, Volume: 25, Issue:5

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cause of Death; Cyclophosphamide; Doxorubicin; Female; Geriatric Assessment; Humans; Male; Melphalan; Multiple Myeloma; Prednisone; Prognosis; Survival Rate; Vincristine

1996
Standard therapy versus autologous transplantation in multiple myeloma.
    Hematology/oncology clinics of North America, 1997, Volume: 11, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Prospective Studies; Vincristine

1997
Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Cancer, 1997, Apr-15, Volume: 79, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cross-Over Studies; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine

1997
Australian Leukaemia Study Group myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma.
    British journal of haematology, 1997, Volume: 97, Issue:1

    Topics: Activities of Daily Living; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Prednisone; Quality of Life; Recombinant Proteins; Remission Induction; Time Factors; Treatment Failure; Treatment Outcome

1997
Impact of high-dose salvage therapy (BEAM) on overall survival in younger patients with advanced large-cell lymphomas entered into BNLI trials.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Staging; Podophyllotoxin; Prednisone; Salvage Therapy; Treatment Outcome; Vincristine

1997
Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
    Bone marrow transplantation, 1997, Volume: 20, Issue:12

    Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases; Middle Aged; Prednisone; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiography; Respiratory Function Tests; Respiratory Sounds; Severity of Illness Index

1997
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
    British journal of cancer, 1998, Volume: 77, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methotrexate; Methylprednisolone; Middle Aged; Mitomycins; Prednisone; Prospective Studies; Treatment Outcome; Vincristine

1998
Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology).
    Leukemia, 1998, Volume: 12, Issue:7

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Prospective Studies; Recombinant Proteins; Remission Induction; Therapeutics; Vincristine

1998
[Level of interleukin-6 (IL-6), soluble interleukin-6 receptors (sIL-6R) and tumor necrosis factor alpha (TNF-alpha) in untreated and progressing multiple myeloma].
    Polskie Archiwum Medycyny Wewnetrznej, 1998, Volume: 99, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease Progression; Female; Humans; Interleukin-6; Kidney Failure, Chronic; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Survival Rate; Tumor Necrosis Factor-alpha; Vincristine

1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85).
    British journal of haematology, 1998, Volume: 103, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine

1998
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Amyloidosis; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Prednisone; Prospective Studies; Survival Rate; Vincristine

1999
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Cancer, 1999, Sep-15, Volume: 86, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Carmustine; Cyclophosphamide; Hematologic Diseases; Humans; Infections; Interferon Type I; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Recombinant Proteins; Survival Analysis; Vincristine

1999
Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized stud
    European journal of haematology, 2001, Volume: 66, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Greece; Humans; Interferon alpha-2; Interferon-alpha; Life Tables; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine

2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine

2001
The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Survival Rate; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation

2000
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.
    The hematology journal : the official journal of the European Haematology Association, 2001, Volume: 2, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cause of Death; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Remission Induction; Survival Analysis; Survival Rate; Vincristine

2001
[Effectiveness of high-dose polychemotherapy and autologous hemopoietic cell transplantation in patients with low-grade non-Hodgkin lymphoma].
    Voprosy onkologii, 2002, Volume: 48, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Prednisone; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine

2002
[Effectiveness of dose-intensive polychemotherapy with autologous hemopoietic cell transplantation for high-grade non-Hodgkin lymphoma].
    Voprosy onkologii, 2003, Volume: 49, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Prednisone; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine

2003
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.
    Blood, 2005, Dec-01, Volume: 106, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Male; Melphalan; Multiple Myeloma; Prednisone; Remission Induction; Spain; Survival Analysis; Treatment Outcome; Vincristine

2005
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Feb-20, Volume: 24, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Chemotherapy, Adjuvant; Clinical Protocols; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Interferons; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prospective Studies; Radiotherapy, Adjuvant; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Treatment Outcome; United States; Vincristine; Whole-Body Irradiation

2006
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
    Blood, 2006, Jun-15, Volume: 107, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine

2006
Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation.
    Cancer, 2006, May-01, Volume: 106, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

2006
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    Haematologica, 2006, Volume: 91, Issue:5

    Topics: Adult; Age Factors; Aged; Antigens, CD34; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2006
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Germany; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine

2007
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
    European journal of haematology, 2008, Volume: 80, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Risk Assessment; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine

2008
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2008
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology
    Cancer, 2009, May-15, Volume: 115, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease-Free Survival; Female; Humans; Interferon Type I; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Recombinant Proteins; Survival Rate; Vincristine

2009
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult

2010
Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma.
    Veterinary and comparative oncology, 2015, Volume: 13, Issue:3

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carmustine; Disease-Free Survival; Dog Diseases; Dogs; Fat Emulsions, Intravenous; Female; Kaplan-Meier Estimate; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Pilot Projects; Prednisone; Vincristine

2015
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
    British journal of haematology, 2014, Volume: 167, Issue:3

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine

2014
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
    Haematologica, 2017, Volume: 102, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult

2017
Rituximab-PECC induction followed by
    British journal of haematology, 2019, Volume: 187, Issue:3

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cyclophosphamide; Disease-Free Survival; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Survival Rate; Vindesine

2019
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
    British journal of haematology, 2020, Volume: 190, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Netherlands; Prednisone; Progression-Free Survival; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Failure; Vincristine; Young Adult

2020

Other Studies

166 other study(ies) available for prednisone and carmustine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse.
    Lancet (London, England), 1976, May-01, Volume: 1, Issue:7966

    Topics: Alkylating Agents; Blood Cell Count; Carmustine; Cell Count; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Injections, Intravenous; Multiple Myeloma; Prednisone; Recurrence; Remission, Spontaneous

1976
Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications.
    The American journal of medicine, 1977, Volume: 63, Issue:4

    Topics: Adult; Bone Marrow; Carmustine; Cytarabine; Diploidy; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphocytes; Male; Maryland; Middle Aged; Prednisone; Retrospective Studies; Splenectomy; Vincristine

1977
Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
    Haematologica, 1978, Volume: 63, Issue:1

    Topics: Adult; Aged; Alkylating Agents; Carmustine; Cyclophosphamide; Drug Evaluation; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1978
Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.
    Cancer, 1979, Volume: 43, Issue:5

    Topics: Carmustine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prednisone; Pulmonary Fibrosis; Radiography

1979
Pulmonary toxicity in cancer chemotherapy.
    Annals of internal medicine, 1979, Volume: 91, Issue:3

    Topics: Antineoplastic Agents; Carmustine; Female; Humans; Lung Diseases; Neoplasms; Pneumonia; Prednisone

1979
Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma.
    Blood, 1979, Volume: 54, Issue:4

    Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Multiple Myeloma; Neoplasm Staging; Nitrosourea Compounds; Prednisone; Risk

1979
Multiple myeloma: results with the M-2 protocol in a community hospital.
    The Journal of the American Osteopathic Association, 1979, Volume: 78, Issue:12

    Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Hospitals, Community; Humans; Melphalan; Multiple Myeloma; Prednisone; Vincristine

1979
Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survival.
    Cancer, 1978, Volume: 42, Issue:4

    Topics: Aged; Antineoplastic Agents; Carmustine; Cell Differentiation; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphocytosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Time Factors; Vincristine

1978
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
    The American journal of medicine, 1977, Volume: 63, Issue:6

    Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Remission, Spontaneous; Time Factors; Vincristine

1977
Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein.
    The Journal of clinical investigation, 1978, Volume: 61, Issue:1

    Topics: Adult; Aged; Bence Jones Protein; Carmustine; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone

1978
A morphologic study of opportunistic cerebral toxoplasmosis.
    Acta neuropathologica, 1978, Jun-30, Volume: 42, Issue:3

    Topics: Aged; Brain Diseases; Carmustine; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Radionuclide Imaging; Tomography, X-Ray Computed; Toxoplasmosis; Vinblastine

1978
Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma.
    Cancer, 1978, Volume: 42, Issue:3

    Topics: Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Remission, Spontaneous; Time Factors

1978
Treatment of plasma cell myeloma with cytotoxic agents.
    Archives of internal medicine, 1975, Volume: 135, Issue:1

    Topics: Acute Disease; Alkylating Agents; Bence Jones Protein; Bone Neoplasms; Carmustine; Cell Count; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Mechlorethamine; Melphalan; Multiple Myeloma; Myeloma Proteins; Prednisone; Remission, Spontaneous; Time Factors

1975
Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
    The Journal of clinical investigation, 1975, Volume: 55, Issue:3

    Topics: Amino Acid Sequence; Antineoplastic Agents; Bence Jones Protein; Bone Marrow; Bone Marrow Cells; Carmustine; Cyclophosphamide; Electrophoresis; Electrophoresis, Starch Gel; Female; Humans; Immunodiffusion; Immunoelectrophoresis; Immunoglobulin Fragments; Melphalan; Middle Aged; Molecular Weight; Multiple Myeloma; Prednisone; Proteinuria

1975
Letter: Maintenance therapy in myeloma: risk versus benefit.
    British medical journal, 1975, Jun-07, Volume: 2, Issue:5970

    Topics: Carmustine; Humans; Leukemia, Myeloid, Acute; Melphalan; Multiple Myeloma; Prednisone

1975
Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.
    Cancer, 1976, Volume: 37, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Asparaginase; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Infant; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Prednisone; Remission, Spontaneous; Spinal Neoplasms; Thioguanine; Vincristine

1976
Pancreatic carcinoma as a sequel to therapy of lymphoma.
    Journal of surgical oncology, 1976, Volume: 8, Issue:6

    Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Agents; Carmustine; Cyclophosphamide; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Radiation-Induced; Pancreatic Neoplasms; Prednisone; Radiotherapy; Radiotherapy Dosage; Stomach Neoplasms; Vincristine

1976
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Cancer, 1975, Volume: 36, Issue:6

    Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine

1975
Correlation of delayed hypersensitivity responses with chemotherapeutic results in advanced Hodgkin's disease.
    Cancer, 1975, Volume: 36, Issue:3

    Topics: Carmustine; Drug Therapy, Combination; Hodgkin Disease; Hypersensitivity, Delayed; Prednisone; Procarbazine; Skin Tests; Vinblastine; Vincristine

1975
Non-Hodgkin's lymphoma in children.
    Medical and pediatric oncology, 1975, Volume: 1, Issue:3

    Topics: Adolescent; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Hydroxyurea; Lymphoma; Male; Methotrexate; Neoplasm Metastasis; Nitrogen Mustard Compounds; Peripheral Nervous System Neoplasms; Prednisone; Prognosis; Thioguanine; Vincristine

1975
Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy.
    Cancer, 1976, Volume: 37, Issue:1

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Lymphoma; Male; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Prednisone; Thioguanine; Vinblastine; Vincristine

1976
Non-secretory multiple myeloma presenting as primary plasma cell leukaemia.
    Postgraduate medical journal, 1992, Volume: 68, Issue:800

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Leukemia, Plasma Cell; Melphalan; Multiple Myeloma; Prednisone; Vincristine

1992
Combination therapy of M2-protocol and interferon-alpha as remission induction in refractory multiple myeloma.
    Haematologia, 1991, Volume: 24, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Remission Induction; Vincristine

1991
[Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].
    Sangre, 1991, Volume: 36, Issue:5

    Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Male; Melphalan; Methotrexate; Multiple Myeloma; Prednisone; Risk; Vincristine

1991
Waldenström's macroglobulinemia.
    Cancer investigation, 1991, Volume: 9, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Male; Melphalan; Prednisone; Vincristine; Waldenstrom Macroglobulinemia

1991
Autopsy-documented cure of multiple myeloma 14 years after M2 chemotherapy.
    Cancer, 1990, Oct-01, Volume: 66, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Carmustine; Cyclophosphamide; Female; Humans; Melphalan; Multiple Myeloma; Prednisone; Remission Induction; Vincristine

1990
Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
    Pathologie-biologie, 1990, Volume: 38, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Humans; Interferon alpha-2; Interferon-alpha; Melphalan; Multiple Myeloma; Prednisone; Recombinant Proteins; Vincristine

1990
Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease.
    Bone marrow transplantation, 1990, Volume: 5, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Evaluation Studies as Topic; Hodgkin Disease; Humans; Male; Melphalan; Prednisone; Premedication; Remission Induction; Vincristine

1990
Allogeneic marrow transplantation for refractory Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine

1989
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
    Cancer, 1985, Jan-15, Volume: 55, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine

1985
[The effect of chemotherapy on survival time in advanced breast carcinoma].
    Deutsche medizinische Wochenschrift (1946), 1989, Jun-16, Volume: 114, Issue:24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Postoperative Care; Prednisone; Retrospective Studies; Time Factors; Vincristine

1989
[Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
    Sangre, 1989, Volume: 34, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Leukemia, Plasma Cell; Male; Melphalan; Middle Aged; Prednisone; Remission Induction; Time Factors; Vincristine

1989
[Plasma cell leukemia].
    Sangre, 1989, Volume: 34, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Prednisone; Time Factors; Vincristine

1989
Diffuse well-differentiated lymphocytic lymphoma: chemotherapy with BCNU, cyclophosphamide, vincristine, melphalan and prednisone.
    Oncology, 1988, Volume: 45, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Melphalan; Middle Aged; Prednisone; Vincristine

1988
[Monoclonal gammapathy of indeterminate origin and myeloma].
    Revue medicale de Liege, 1988, Apr-15, Volume: 43, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Drug Therapy, Combination; Humans; Hypergammaglobulinemia; Interferon Type I; Melphalan; Methylprednisolone; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Prednisone; Vincristine

1988
Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.
    Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1

    Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia, Lymphoid; Methotrexate; Middle Aged; Prednisone; Thioguanine; Vincristine

1987
M-2 protocol for melphalan-resistant and relapsing multiple myeloma.
    European journal of haematology, 1988, Volume: 40, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; Carmustine; Cyclophosphamide; Drug Resistance; Hemoglobins; Humans; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Pain; Prednisone; Time Factors; Vincristine

1988
Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
    Cancer, 1988, Jul-15, Volume: 62, Issue:2

    Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Nutritional Status; Prednisone; Prognosis; Time Factors; Vincristine

1988
[Treatment of acute adult myeloblastic leukemia with intensive chemotherapy].
    Sangre, 1986, Volume: 31, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Combinations; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Male; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Middle Aged; Mitoguazone; Prednisone; Thioguanine; Vincristine

1986
Complete remission in plasma cell leukaemia.
    British journal of haematology, 1987, Volume: 66, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Leukemia, Plasma Cell; Melphalan; Middle Aged; Prednisone; Remission Induction; Vincristine

1987
Pseudohypercalcemia and hyperviscosity with neurological manifestations in multiple myeloma.
    Israel journal of medical sciences, 1986, Volume: 22, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Viscosity; Carmustine; Cyclophosphamide; Humans; Hypercalcemia; Male; Melphalan; Multiple Myeloma; Paralysis; Plasmapheresis; Prednisone; Seizures; Serum Globulins; Vincristine

1986
[Results with the use of the M-2 protocol in plasmacytoma].
    Deutsche medizinische Wochenschrift (1946), 1986, May-30, Volume: 111, Issue:22

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Vincristine

1986
Treatment of alkylating resistant multiple myeloma with vincristine, BCNU, doxorubicin and prednisone (VBAP).
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Female; Humans; Male; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1986
Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol.
    Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1985
[Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
    Revista clinica espanola, 1985, Volume: 176, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Male; Melphalan; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Vincristine

1985
Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol).
    Oncology, 1985, Volume: 42, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Urea Nitrogen; Carmustine; Cyclophosphamide; Humans; Immunoglobulins; Leukemia, Monocytic, Acute; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Prognosis; Time Factors; Vincristine

1985
[Diagnosis and treatment of Waldenstrom's macroglobulinemia: 4 case reports].
    Zhonghua nei ke za zhi, 1985, Volume: 24, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Diagnostic Errors; Female; Humans; Male; Melphalan; Prednisone; Vincristine; Waldenstrom Macroglobulinemia

1985
Combination chemotherapy with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for chronic lymphocytic leukemia (stages III and IV).
    Oncology, 1985, Volume: 42, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Leukemia, Lymphoid; Melphalan; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Vincristine

1985
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine

1973
Acute leukemia in Hodgkin's disease.
    Cancer, 1974, Volume: 33, Issue:5

    Topics: Adult; Bleomycin; Carmustine; Chlorambucil; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Time Factors; Vinblastine

1974
Prognosis and survival with extranodal Hodgkin's disease.
    Journal of chronic diseases, 1974, Volume: 27, Issue:9-10

    Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Palliative Care; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Time Factors; Vinblastine; Vinca Alkaloids; Vincristine

1974
Combination chemotherapy for spontaneous AKR lymphoma.
    Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Lymphoma; Methotrexate; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Palmitic Acids; Prednisone; Remission, Spontaneous; Rodent Diseases; Spleen; Splenomegaly; Thymus Gland; Time Factors; Vincristine

1974
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Cancer research, 1974, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine

1974
Chromosomes and causation of human cancer and leukemia. IX. Prognostic and therapeutic value of chromosomal findings in acute myeloblastic leukemia.
    Cancer, 1974, Volume: 33, Issue:6

    Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bone Marrow Cells; Carmustine; Chromosome Aberrations; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitosis; Nitrosourea Compounds; Prednisone; Prognosis; Thioguanine; Time Factors; Vincristine

1974
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
    Cancer, 1974, Volume: 33, Issue:6

    Topics: Administration, Oral; Adolescent; Age Factors; Antineoplastic Agents; Asparaginase; Carmustine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Hydroxyurea; Infant; Infections; Injections, Intravenous; Leukemia, Lymphoid; Male; Meningitis; Methotrexate; Prednisone; Remission, Spontaneous; Thioguanine; Vincristine

1974
Comparative results obtained in the treatment of acute leukemia.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1973, Volume: 43

    Topics: Antineoplastic Agents; Asparaginase; Carmustine; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Meningitis; Methotrexate; Prednisone; Thioguanine; Vincristine

1973
[Neuromeningeal irradiation during the treatment of acute lymphoblastic leukemia].
    Strahlentherapie, 1974, Volume: 148, Issue:6

    Topics: Acute Disease; Age Factors; Asparaginase; Carmustine; Central Nervous System; Child; Child, Preschool; Cobalt Radioisotopes; Cyclophosphamide; Female; Humans; Leukemia, Lymphoid; Male; Methotrexate; Prednisone; Radioisotope Teletherapy; Radiotherapy Dosage; Time Factors; Vincristine

1974
Treatment of Hodgkin's disease and other malignant lymphomas.
    Journal of surgical oncology, 1973, Volume: 5, Issue:6

    Topics: Alkylating Agents; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine

1973
Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera.
    Journal of the National Cancer Institute, 1974, Volume: 52, Issue:3

    Topics: Antineoplastic Agents; Blood Bactericidal Activity; Carmustine; Cell Membrane; Complement System Proteins; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Escherichia coli; Fluorouracil; Humans; Immunoglobulins; Leukemia; Mechlorethamine; Methotrexate; Microbial Sensitivity Tests; Muramidase; Prednisone; Vincristine

1974
Eastern cooperative oncology group studies.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Antineoplastic Agents; Blood Cell Count; Carmustine; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine

1973
Combination chemotherapy in Hodgkin's disease.
    Danish medical bulletin, 1973, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carmustine; Child; Female; Hodgkin Disease; Humans; Injections, Intravenous; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Recurrence; Time Factors; Vinblastine; Vincristine

1973
Extra-axial spread of medulloblastoma.
    Cancer, 1973, Volume: 31, Issue:5

    Topics: Autopsy; Brain Neoplasms; Carmustine; Cranial Fossa, Posterior; Femoral Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Prednisone; Vincristine

1973
Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
    JAMA, 1973, Jan-08, Volume: 223, Issue:2

    Topics: Antineoplastic Agents; Benzoates; Carmustine; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine

1973
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Adult; Age Factors; Antineoplastic Agents; Biopsy; Carmustine; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vinblastine; Vincristine

1973
[Progress in combination chemotherapy of malignant lymphomas (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1973, Dec-18, Volume: 62, Issue:51

    Topics: Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Streptonigrin; Vinblastine; Vincristine

1973
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
    Cancer, 1974, Volume: 33, Issue:2

    Topics: Adult; Aged; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1974
Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:1

    Topics: Administration, Oral; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carmustine; Female; Humans; Nitroso Compounds; Nitrosourea Compounds; Prednisone; Time Factors; Urea

1972
The phase II study: some reflections, particularly concerning disseminated breast cancer.
    Cancer chemotherapy reports. Part 3, 1972, Volume: 3, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Cyclohexanes; Cyclophosphamide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Lung Neoplasms; Mitomycins; Neoplasm Metastasis; Nitrosourea Compounds; Prednisone

1972
Management of the indolent non-Hodgkin's lymphomas.
    Seminars in oncology, 1980, Volume: 7, Issue:3

    Topics: Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Radiography; Vincristine

1980
Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
    Cancer treatment reports, 1984, Volume: 68, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Doxorubicin; Drug Evaluation; Drug Resistance; Humans; Leukopenia; Multiple Myeloma; Prednisone; Recurrence; Vincristine

1984
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimen.
    Cancer, 1983, May-01, Volume: 51, Issue:9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Histological Techniques; Humans; Leukopenia; Lymphoma; Prednisone; Prognosis; Thrombocytopenia; Vincristine

1983
Long-term survival of patients with multiple myeloma and acute renal failure at presentation.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1983, Volume: 2, Issue:5

    Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Renal Dialysis; Time Factors; Vincristine

1983
Serum-free light chain analysis by crossed immunoelectrophoresis: correlation with plasmapheresis in light chain disease nephropathy.
    American journal of hematology, 1983, Volume: 15, Issue:1

    Topics: Acute Kidney Injury; Aged; Allopurinol; Calcitonin; Carmustine; Counterimmunoelectrophoresis; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunoglobulin lambda-Chains; Immunoglobulin Light Chains; Male; Melphalan; Paraproteinemias; Peritoneal Dialysis; Plasmapheresis; Prednisone; Vincristine

1983
Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
    Oncology, 1984, Volume: 41, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Resistance; Female; Humans; Lung Diseases; Middle Aged; Mitomycin; Mitomycins; Nausea; Neoplasm Metastasis; Pilot Projects; Prednisone; Thrombocytopenia; Vincristine; Vomiting

1984
Treatable meningeal involvement in Waldenström's macroglobulinemia.
    Annals of internal medicine, 1984, Volume: 101, Issue:3

    Topics: Aged; Carmustine; Central Nervous System Diseases; Drug Therapy, Combination; Female; Humans; Immunoglobulin kappa-Chains; Immunoglobulin M; Lymphocytes; Meninges; Plasma Cells; Prednisone; Waldenstrom Macroglobulinemia

1984
[Systemic light-chain disease as a complication of plasmacytoma].
    Deutsche medizinische Wochenschrift (1946), 1984, Sep-14, Volume: 109, Issue:37

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Bone Marrow Cells; Carmustine; Cyclophosphamide; Humans; Hypergammaglobulinemia; Hypertension, Renal; Immunoglobulin kappa-Chains; Immunoglobulin Light Chains; Male; Melphalan; Middle Aged; Nephrotic Syndrome; Plasma Cells; Plasmacytoma; Prednisone; Vincristine

1984
Comparison of M-2 protocol with COP in patients with nodular lymphoma.
    Oncology, 1984, Volume: 41, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Cyclophosphamide; Humans; Lymphoma; Melphalan; Middle Aged; Neoplasm Staging; Prednisone; Probability; Time Factors; Vincristine

1984
[Therapy of multiple myeloma. Results of sequential treatment with melphalan-prednisolone and the M2 protocol].
    Deutsche medizinische Wochenschrift (1946), 1984, Jun-29, Volume: 109, Issue:26

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Creatinine; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Vincristine

1984
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma.
    Blut, 1984, Volume: 49, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Remission, Spontaneous; Vincristine

1984
[Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1984, Volume: 25, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1984
Treatment of multiple myeloma with M-2 protocol and without maintenance therapy.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Immunoglobulins; Male; Melphalan; Middle Aged; Multiple Myeloma; Paraproteins; Prednisone; Time Factors; Vincristine

1983
Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenström macroglobulinemia: preliminary report.
    Blood, 1982, Volume: 59, Issue:5

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunoglobulin M; Male; Melphalan; Middle Aged; Prednisone; Prognosis; Vincristine; Waldenstrom Macroglobulinemia

1982
Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
    Cancer treatment reports, 1982, Volume: 66, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leukopenia; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prospective Studies; Thrombocytopenia; Vincristine

1982
A five-drug combination in the treatment of metastatic breast cancer.
    Cancer clinical trials, 1981, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prednisone

1981
[Value of successive chemotherapy in multiple myeloma of bone. Prospective study over 4 years].
    Revue du rhumatisme et des maladies osteo-articulaires, 1980, Volume: 47, Issue:2

    Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1980
Therapy of myeloma.
    Blood, 1980, Volume: 55, Issue:6

    Topics: Carmustine; Cyclophosphamide; Humans; Multiple Myeloma; Prednisone

1980
Visual hallucinations following treatment with vincristine.
    Clinical and laboratory haematology, 1994, Volume: 16, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Hallucinations; Humans; Lymphoma, T-Cell; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Salvage Therapy; Serotonin; Structure-Activity Relationship; Vincristine

1994
[Pneumonia caused by Salmonella in a patient with myeloma].
    Sangre, 1995, Volume: 40, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Immunocompromised Host; Male; Melphalan; Middle Aged; Multiple Myeloma; Pneumonia, Bacterial; Prednisone; Salmonella Infections; Vincristine

1995
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
    Blood, 1995, Nov-15, Volume: 86, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Glyoxal; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multivariate Analysis; Prednimustine; Prednisolone; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine

1995
Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma.
    Blood, 1995, Oct-15, Volume: 86, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Graft Rejection; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Lymphoma, Follicular; Melphalan; Middle Aged; Pancytopenia; Podophyllotoxin; Prednisone; Prognosis; Teniposide; Treatment Outcome; Vincristine; Whole-Body Irradiation

1995
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:4-5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Leukemia, Myelomonocytic, Acute; Luteinizing Hormone; Melphalan; Menotropins; Ovulation Induction; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy, Multiple; Primary Ovarian Insufficiency; Remission Induction; Teniposide; Thioguanine; Vincristine

1993
Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine (BCNU).
    Chest, 1995, Volume: 107, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Forced Expiratory Volume; Humans; Lung Diseases; Lymphoma; Prednisone; Pulmonary Diffusing Capacity; Retrospective Studies; Spirometry; Vital Capacity

1995
The therapeutic efficacy of VBCMP-M2 protocol in multiple myeloma.
    Haematologia, 1994, Volume: 26, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Survival; Vincristine

1994
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infant, Newborn; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Melphalan; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy Outcome; Procarbazine; Remission Induction; Salvage Therapy; Vincristine

1994
Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Ependymoma; Female; Humans; Hydroxyurea; Infant; Male; Neuroectodermal Tumors, Primitive, Peripheral; Prednisone; Procarbazine; Survival Analysis; Vincristine

1994
Pentostatin increases the acute toxicity of high dose cyclophosphamide.
    Bone marrow transplantation, 1993, Volume: 12, Issue:3

    Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Pentostatin; Prednisone; Rats; Rats, Inbred Lew; Salvage Therapy; Shock, Cardiogenic; Ventricular Fibrillation; Vidarabine; Vincristine

1993
[Results of alternating treatment of multiple myeloma--cytostatics VBMCP and recombinant interferon alfa-2B].
    Polskie Archiwum Medycyny Wewnetrznej, 1993, Volume: 90, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Recombinant Proteins; Survival Rate; Vincristine

1993
Chemotherapy-associated changes in 31P MRS spectra of sera from patients with multiple myeloma.
    NMR in biomedicine, 1995, Volume: 8, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium; Carmustine; Cholesterol; Cyclophosphamide; Female; Humans; Immunoglobulin G; Lipoproteins; Magnetic Resonance Spectroscopy; Male; Melphalan; Middle Aged; Multiple Myeloma; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Prednisone; Reference Values; Sphingomyelins; Vincristine

1995
Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
    European journal of haematology, 1996, Volume: 56, Issue:3

    Topics: Aclarubicin; Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Finland; Humans; Immunocompromised Host; Incidence; Leukemia; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Pneumonia, Pneumocystis; Prednisone; Premedication; Retrospective Studies; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine

1996
Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Plasma Cell; Lymphocyte Count; Male; Melphalan; Mitoxantrone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Transplantation Conditioning; Vincristine; Whole-Body Irradiation

1996
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Lymphoma, Follicular; Male; Melphalan; Methotrexate; Podophyllotoxin; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vincristine

1996
Conventional induction treatments do not influence overall survival in multiple myeloma.
    British journal of haematology, 1997, Volume: 96, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Melphalan; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine

1997
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
    Bone marrow transplantation, 1997, Volume: 19, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine

1997
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:2

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Leukapheresis; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Risk; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine

1997
Dementia improvement with cytotoxic chemotherapy. A case of Alzheimer disease and multiple myeloma.
    Archives of neurology, 1997, Volume: 54, Issue:4

    Topics: Alzheimer Disease; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vincristine

1997
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
    Leukemia & lymphoma, 1997, Volume: 24, Issue:3-4

    Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vincristine

1997
Multifocal plasmacytoma of hand and foot bones.
    Leukemia & lymphoma, 1996, Volume: 21, Issue:5-6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Combined Modality Therapy; Cyclophosphamide; Female; Fingers; Foot Diseases; Hand Deformities, Acquired; Humans; Melphalan; Metacarpus; Plasmacytoma; Prednisone; Vincristine

1996
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
    Blood, 1997, Jun-15, Volume: 89, Issue:12

    Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Idarubicin; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine

1997
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
    British journal of haematology, 1997, Volume: 99, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vincristine

1997
[The influence of verapamil on platelet function in patients with multiple myeloma].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1997, Volume: 2, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Platelet Aggregation; Platelet Aggregation Inhibitors; Prednisone; Verapamil; Vincristine

1997
[Intensive treatment of T-cell-rich B lymphoma].
    Sangre, 1998, Volume: 43, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Lymphoma, B-Cell; Male; Melphalan; Podophyllotoxin; Prednisone; Remission Induction; T-Lymphocyte Subsets; Vincristine

1998
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.
    Bone marrow transplantation, 1998, Volume: 21, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Transplantation, Autologous; Vincristine

1998
High-dose chemotherapy and autologous transplantation in lymphomatous polyposis in second remission: three case reports and literature review.
    Bone marrow transplantation, 1998, Volume: 22, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Polyps; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Prednisone; Transplantation, Autologous; Vincristine

1998
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy.
    Blood, 1998, Aug-01, Volume: 92, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Chromosomes, Human, Pair 17; Cyclophosphamide; Dexamethasone; Female; Gene Deletion; Genes, p53; Humans; In Situ Hybridization, Fluorescence; Interphase; Karyotyping; Life Tables; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine

1998
DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:11

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Nucleus; Chlorambucil; Cyclophosphamide; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Ethylnitrosourea; Guanine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Prednisone; Vincristine

1997
Non-secretory solitary plasmacytoma of the spleen.
    Medical oncology (Northwood, London, England), 1998, Volume: 15, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Male; Melphalan; Middle Aged; Plasmacytoma; Prednisone; Splenectomy; Splenic Neoplasms; Vincristine

1998
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Bone marrow transplantation, 1999, Volume: 23, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bone Marrow; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Proteins; Plasmacytoma; Prednisone; Salvage Therapy; Survival Analysis; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

1999
Amyloidosis: recognition, confirmation, prognosis, and therapy.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:5

    Topics: Aged; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Diagnosis, Differential; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Prednisone; Prognosis; Vincristine

1999
[Acute and chronic renal failure in patients with myeloma].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:7

    Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Hemodiafiltration; Hemofiltration; Humans; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Peritoneal Dialysis; Prednisone; Renal Dialysis; Time Factors; Vincristine

1999
[Lumbago radiating to the right leg as a form of onset of multiple myeloma in a 33-year-old patient].
    Anales de medicina interna (Madrid, Spain : 1984), 1999, Volume: 16, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Doxorubicin; Humans; Leg; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Multiple Myeloma; Prednisone; Radiography; Treatment Outcome; Vincristine

1999
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    British journal of cancer, 1999, Volume: 81, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine

1999
Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Acute Kidney Injury; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bacterial Proteins; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Diuretics; Doxorubicin; Ethmoid Sinus; Female; Fluid Therapy; Folic Acid; Furosemide; gamma-Glutamyl Hydrolase; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Methotrexate; Paranasal Sinus Neoplasms; Prednisone; Procarbazine; Remission Induction; Vincristine

1999
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Immunization, Passive; Interleukin-2; Male; Melphalan; Middle Aged; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine

1999
Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995.
    Journal of hematotherapy & stem cell research, 1999, Volume: 8, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hospital Costs; Hospital Units; Hospitalization; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Melphalan; Netherlands; Parenteral Nutrition; Patient Isolation; Podophyllotoxin; Prednisone; Retrospective Studies; Transplantation, Autologous; Vincristine

1999
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:4

    Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carmustine; Cohort Studies; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Liver Function Tests; Lung Diseases; Male; Middle Aged; Neoplasm Metastasis; Prednisone; Radiotherapy, Adjuvant; Respiratory Function Tests; Retrospective Studies; Risk Factors; Survival Rate; Syndrome; Transplantation, Autologous; Treatment Outcome

2000
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Harefuah, 2000, Volume: 139, Issue:5-6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vinblastine; Vincristine

2000
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
    Bone marrow transplantation, 2000, Volume: 26, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carmustine; Cefotaxime; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Idarubicin; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Lymphoma, T-Cell; Male; Melphalan; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Prednisone; Recurrence; Rifampin; Splenectomy; Streptococcus pneumoniae; Transplantation Conditioning; Vincristine

2000
[Autograft and multiple myeloma: experience of the Intergroupe Français du Myélome].
    Bulletin du cancer, 2001, Volume: 88, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; France; Humans; Melphalan; Multiple Myeloma; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Transplantation, Autologous; Vincristine

2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
    Blood, 2001, Nov-15, Volume: 98, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine

2001
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine

2001
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Chromosomes, Human, Pair 3; Cyclophosphamide; Cytarabine; Disease-Free Survival; DNA Mutational Analysis; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Genes, bcl-2; Humans; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Point Mutation; Prednisolone; Prednisone; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Transcription Factors; Treatment Outcome; Vincristine

2002
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Idarubicin; Life Tables; Male; Melphalan; Mercaptopurine; Middle Aged; Neoplasm Proteins; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Retrospective Studies; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine

2000
Immunotherapy by non-myeloablative stem cell transplantation: study of the immune reconstitution. Arguments for distinct cell subsets in skin and blood.
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood; Blood Cells; Carmustine; CD8-Positive T-Lymphocytes; Clone Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Female; Graft Survival; Graft vs Host Reaction; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunotherapy; Leukemia, Myeloid; Male; Middle Aged; Minisatellite Repeats; Multiple Myeloma; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; Skin; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation

2000
Composite mycosis fungoides and B-cell chronic lymphocytic leukemia.
    Annals of diagnostic pathology, 2002, Volume: 6, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Fatal Outcome; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Middle Aged; Mycosis Fungoides; Neoplasms, Multiple Primary; Photopheresis; Prednisone; Skin Neoplasms; Vincristine

2002
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
    Leukemia, 2002, Volume: 16, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisone; Survival Rate; Time Factors; Transplantation, Autologous; Vincristine

2002
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytokines; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2003
Testicular plasmacytoma with bone dissemination without medullary plasmacytosis.
    Annals of hematology, 2003, Volume: 82, Issue:8

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Male; Melphalan; Plasma Cells; Plasmacytoma; Prednisone; Skull Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed; Vincristine

2003
Immune thrombocytopenia following successful treatment of cancer in children.
    Pediatric blood & cancer, 2006, Volume: 46, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Carmustine; Child, Preschool; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasms; Platelet Count; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Vincristine

2006
Nephrotic syndrome in patients with peripheral blood stem cell transplant.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:4

    Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Rituximab; Sepsis; Staphylococcal Infections; Tacrolimus; Transplantation Conditioning

2005
Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?
    Annals of hematology, 2005, Volume: 84, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Combined Modality Therapy; Cyclophosphamide; Female; Hodgkin Disease; Humans; Melphalan; Multiple Myeloma; Neoplasms, Second Primary; Prednisone; Procarbazine; Vincristine; Whole-Body Irradiation

2005
Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.
    Bone marrow transplantation, 2006, Volume: 38, Issue:6

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Transformation, Neoplastic; Cyclophosphamide; Cytarabine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Transfusion; Melphalan; Podophyllotoxin; Prednisone; Remission Induction; Rituximab; Time Factors; Vincristine

2006
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Melphalan; Mesna; Postoperative Complications; Prednisone; Radiotherapy, Adjuvant; Transplantation, Autologous; Vidarabine; Vincristine

2008
Refractory multiple myeloma treated with homoharringtonine: report of two cases.
    Annals of hematology, 2007, Volume: 86, Issue:12

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Harringtonines; Homoharringtonine; Humans; Male; Melphalan; Multiple Myeloma; Oxides; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Vincristine; Vindesine

2007
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:33

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lymph Nodes; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vinblastine; Vincristine

2007
pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Protein Processing, Post-Translational; STAT3 Transcription Factor; Transplantation, Autologous; Tumor Suppressor Protein p53; Vincristine

2009
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Down Syndrome; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Ifosfamide; Male; Mesna; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vincristine; Vinorelbine

2009
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine

2010
Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies.
    Human antibodies, 2010, Volume: 19, Issue:1

    Topics: Adult; Aged; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine; Vindesine

2010
Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carmustine; Clinical Trials, Phase I as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Maintenance Chemotherapy; Male; Melphalan; Prednisone; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous; Vincristine

2012
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
    Hematological oncology, 2013, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Carmustine; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rituximab; Salvage Therapy; Stem Cell Transplantation; Thiotepa; Vincristine; Young Adult

2013
[First case in Spain of bacteremia by Methylobacterium thiocyanatum from Hickmann catheter in an immunosuppressed patient with Hodgkin's lymphoma].
    Medicina clinica, 2012, Dec-01, Volume: 139, Issue:13

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Biofilms; Bleomycin; Carmustine; Catheter-Related Infections; Central Venous Catheters; Cisplatin; Cross Infection; Cytarabine; Dacarbazine; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Etoposide; Female; Gemcitabine; Gram-Negative Bacterial Infections; Hodgkin Disease; Humans; Immunocompromised Host; Melphalan; Methylobacterium; Prednisone; Ribotyping; Spain; Vinblastine

2012
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carmustine; Cisplatin; Combined Modality Therapy; Compassionate Use Trials; Crizotinib; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunoconjugates; Lymphocyte Transfusion; Lymphoma, Large-Cell, Anaplastic; Male; Melphalan; Molecular Targeted Therapy; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Prednisone; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Remission Induction; Respiration, Artificial; Respiratory Insufficiency; Transplantation, Homologous; Vincristine

2013
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Lymphoma, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Podophyllotoxin; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult

2015
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    British journal of haematology, 2014, Volume: 165, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine

2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:8

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melphalan; Nitriles; Nitrogen Mustard Compounds; Prednisone; Primary Myelofibrosis; Pyrazines; Pyrazoles; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Rituximab; Vincristine

2014
[Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
    Medicina clinica, 2015, Jun-22, Volume: 144, Issue:12

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine

2015
High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Humans; Infant; Maintenance Chemotherapy; Male; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk; Transplantation, Autologous; Vincristine

2018
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine

2018
Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma.
    American journal of hematology, 2020, Volume: 95, Issue:4

    Topics: Adrenal Cortex Hormones; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Etoposide; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Oxaliplatin; Prednisone; Recurrence; Rituximab; Salvage Therapy; Transplantation, Autologous; Vincristine

2020
Intravascular Large B-Cell Lymphoma: Clinical and Histopathologic Findings.
    The Yale journal of biology and medicine, 2020, Volume: 93, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Blood Vessels; Carmustine; Cyclophosphamide; Cytarabine; Delayed Diagnosis; Diagnosis, Differential; Doxorubicin; Early Detection of Cancer; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Podophyllotoxin; Prednisone; Rituximab; Skin; Skin Neoplasms; Treatment Outcome; Vincristine

2020
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement.
    Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Progression-Free Survival; Retrospective Studies; Rituximab; Vincristine

2022
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab

2022